Overview

Study to Compare Safety and Pharmacokinetics of "CG1801" and "CGL1802" in Healthy Volunteers

Status:
Completed
Trial end date:
2019-05-03
Target enrollment:
Participant gender:
Summary
The objective of this open-label, randomized, 2*2 crossover study is to compare the safety and Pharmacokinetics CG1801 and CGL1802 in Healthy Volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
CrystalGenomics, Inc.